Roswell Biotechnologies is digitizing biology through molecular electronics to elucidate, diagnose and treat disease. The company has developed the world's first molecular electronics chip, the Roswell ME Chip, by integrating single molecules into standard semiconductor chip technology to deliver a powerful biosensor that converges all omics on one platform. The Roswell ME Chip reads a multitude of molecules - enzymes, DNA, RNA, proteins, and small molecules - and for the first time, provides direct real-time electrical detection of single-molecule events on-chip. Designed to overcome the enduring scaling limitations of genomic sequencing technologies, the Roswell ME Chip Platform significantly reduces genomic sequencing's cost and complexity to advance basic and translational research, precision medicine, molecular diagnostics, environmental surveillance, and digital DNA data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is headquartered in San Diego, California.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $32M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | JAM Fund | jamfund.co... |
| - | PTK Capita... | ptkcapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.01.2019 | Series A | $32M | - |
Mentions in press and media 1
| Date | Title | Description |
| 03.01.2019 | Roswell Biotechnologies secures $32 million Series A funding round to revolutionize DNA sequencing through molecular electronics | Roswell Biotechnologies, a life science startup that is revolutionizing DNA sequencing by harnessing the power of molecular electronics, has closed a $32 million round of Series A financing to support the development of their disruptive DNA... |